COMP <GO>
ENSG vs LLY // NET PROFIT MARGIN
The Ensign Group Inc. (NASDAQ) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: ENSG 4
— LLY 11
▲ NET PROFIT MARGIN LEADER: LLY
LAST: $181.52 (-2.58%) • MKT CAP: $10.87B
net-margins
6.80%
LAST: $1,417.54 (+3.19%) • MKT CAP: $1.33T
net-margins
31.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ENSG VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ENSG | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 20.10% | 83.64% | -63.54 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 18.00% | 32.36% | -14.36 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation | 17.0x | 36.4x | -19.42 | ENSG | /valuation <GO> |
| Free Cash Flow Yield | 3.11% | 2.30% | +0.81 | ENSG | /fcf-yield <GO> |
| Operating Margin | 8.50% | 40.21% | -31.71 | LLY | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 6.80% | 31.90% | -25.10 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 18.80% | 45.51% | -26.71 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.13% | 0.49% | -0.36 | LLY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.73 | 9.29 | -5.56 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 9/9 | -1.00 | LLY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 6.77% | -0.27 | ENSG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.9 | 77.9 | -21.94 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.89 | 0.51 | +0.38 | ENSG | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.5x | 26.3x | +0.25 | LLY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.87B | $1.33T | -$1.32T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ENSG REV | LLY REV | ENSG GROSS % | LLY GROSS % | ENSG FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.03B | $65.18B | 20.1% | 83.0% | $337.8M | $16.81B |
| FY 2024 | $4.24B | $45.04B | 20.3% | 81.3% | $156.5M | $8.82B |
| FY 2023 | $3.71B | $34.12B | 44.0% | 79.3% | $209.8M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ENSG // BETA 0.89
LLY // BETA 0.51